Cargando…

A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)

OBJECTIVE: The objective of the study is to explore the long-term effectiveness and tolerability of metoclopramide in the treatment of CIH. METHOD: This study is a retrospective, observational cohort study of patients prescribed metoclopramide for CIH at the South London & Maudsley (SLaM) NHS Fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Livermore, Cecilia, White, Hannah, Bailey, Loren, Osborne, Ian, Oloyede, Ebenezer, Dzahini, Olubanke, Whiskey, Eromona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019988/
https://www.ncbi.nlm.nih.gov/pubmed/35443629
http://dx.doi.org/10.1186/s12888-022-03940-0
_version_ 1784689426729795584
author Livermore, Cecilia
White, Hannah
Bailey, Loren
Osborne, Ian
Oloyede, Ebenezer
Dzahini, Olubanke
Whiskey, Eromona
author_facet Livermore, Cecilia
White, Hannah
Bailey, Loren
Osborne, Ian
Oloyede, Ebenezer
Dzahini, Olubanke
Whiskey, Eromona
author_sort Livermore, Cecilia
collection PubMed
description OBJECTIVE: The objective of the study is to explore the long-term effectiveness and tolerability of metoclopramide in the treatment of CIH. METHOD: This study is a retrospective, observational cohort study of patients prescribed metoclopramide for CIH at the South London & Maudsley (SLaM) NHS Foundation Trust. RESULTS: Of the 96 patients identified, 14 patients were eligible for inclusion in our study. Five patients continued treatment with a mean duration of 27 months (SD = 17.8), and one patient continued until transfer with a duration of 3 months. Eight patients discontinued treatment after a mean duration of 8 months. CONCLUSION: Metoclopramide may be an effective and tolerated drug in CIH, but more data is required to establish its place in the pharmacotherapy of this condition.
format Online
Article
Text
id pubmed-9019988
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90199882022-04-21 A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH) Livermore, Cecilia White, Hannah Bailey, Loren Osborne, Ian Oloyede, Ebenezer Dzahini, Olubanke Whiskey, Eromona BMC Psychiatry Research OBJECTIVE: The objective of the study is to explore the long-term effectiveness and tolerability of metoclopramide in the treatment of CIH. METHOD: This study is a retrospective, observational cohort study of patients prescribed metoclopramide for CIH at the South London & Maudsley (SLaM) NHS Foundation Trust. RESULTS: Of the 96 patients identified, 14 patients were eligible for inclusion in our study. Five patients continued treatment with a mean duration of 27 months (SD = 17.8), and one patient continued until transfer with a duration of 3 months. Eight patients discontinued treatment after a mean duration of 8 months. CONCLUSION: Metoclopramide may be an effective and tolerated drug in CIH, but more data is required to establish its place in the pharmacotherapy of this condition. BioMed Central 2022-04-20 /pmc/articles/PMC9019988/ /pubmed/35443629 http://dx.doi.org/10.1186/s12888-022-03940-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Livermore, Cecilia
White, Hannah
Bailey, Loren
Osborne, Ian
Oloyede, Ebenezer
Dzahini, Olubanke
Whiskey, Eromona
A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
title A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
title_full A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
title_fullStr A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
title_full_unstemmed A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
title_short A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
title_sort retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (cih)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019988/
https://www.ncbi.nlm.nih.gov/pubmed/35443629
http://dx.doi.org/10.1186/s12888-022-03940-0
work_keys_str_mv AT livermorececilia aretrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT whitehannah aretrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT baileyloren aretrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT osborneian aretrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT oloyedeebenezer aretrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT dzahiniolubanke aretrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT whiskeyeromona aretrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT livermorececilia retrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT whitehannah retrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT baileyloren retrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT osborneian retrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT oloyedeebenezer retrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT dzahiniolubanke retrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih
AT whiskeyeromona retrospectivecasenotesreviewoftheeffectivenessandtolerabilityofmetoclopramideinthetreatmentofclozapineinducedhypersalivationcih